S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)

Avadel Pharmaceuticals (AVDL) Short Interest Ratio & Short Volume

$13.72
+0.94 (+7.36%)
(As of 03/1/2024 ET)

Avadel Pharmaceuticals Short Interest Data

Current Short Volume
8,860,000 shares
Previous Short Volume
8,480,000 shares
Change Vs. Previous Month
+4.48%
Dollar Volume Sold Short
$125.81 million
Short Interest Ratio / Days to Cover
9.2
Last Record Date
February 15, 2024
Outstanding Shares
89,806,000 shares
Percentage of Shares Shorted
9.87%
Today's Trading Volume
4,108,378 shares
Average Trading Volume
1,229,476 shares
Today's Volume Vs. Average
334%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Avadel Pharmaceuticals ?

Sign up to receive the latest short interest report for Avadel Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

AVDL Short Interest Over Time

AVDL Days to Cover Over Time

AVDL Percentage of Float Shorted Over Time


Avadel Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/15/20248,860,000 shares $125.81 million +4.5%N/A9.2 $14.20
1/31/20248,480,000 shares $122.03 million +30.1%N/A9.2 $14.39
1/15/20246,520,000 shares $96.50 million +26.6%N/A7.7 $14.80
12/31/20235,150,000 shares $72.72 million +2.2%N/A6.8 $14.12
12/15/20235,040,000 shares $70.51 million +6.1%N/A7.5 $13.99
11/30/20234,750,000 shares $54.82 million -0.4%N/A7.6 $11.54
11/15/20234,770,000 shares $52.09 million +19.3%N/A8.3 $10.92
10/31/20234,000,000 shares $39.44 million +4.4%N/A6.9 $9.86
10/15/20233,830,000 shares $40.29 million +0.8%N/A6.8 $10.52
9/30/20233,800,000 shares $39.14 million +13.8%N/A6.6 $10.30
9/15/20233,340,000 shares $40.98 million +28.0%N/A5 $12.27
8/31/20232,610,000 shares $35.26 million -15.3%N/A3.5 $13.51
8/15/20233,080,000 shares $42.38 million -1.0%N/A3.9 $13.76
7/31/20233,110,000 shares $43.85 million -8.5%N/A3.7 $14.10
7/15/20233,400,000 shares $52.33 million -8.6%N/A3.4 $15.39
6/30/20233,720,000 shares $61.31 million -21.4%N/A3.8 $16.48
6/15/20234,730,000 shares $70.00 million +16.8%N/A4.6 $14.80
5/31/20234,050,000 shares $56.09 million +20.9%N/A4.4 $13.85
5/15/20233,350,000 shares $48.61 million -13.9%N/A3.7 $14.51
4/30/20233,890,000 shares $40.77 million +4.6%N/A4.5 $10.48
4/15/20233,720,000 shares $36.87 million +24.0%N/A5.8 $9.91
3/31/20233,000,000 shares $27.48 million -24.1%N/A4.9 $9.16
3/15/20233,950,000 shares $36.26 million -0.3%6.9%9 $9.18
2/28/20233,960,000 shares $39.40 million +0.3%7.3%7.9 $9.95
2/15/20233,950,000 shares $33.58 million +7.9%7.2%7.5 $8.50
1/31/20233,660,000 shares $27.54 million +9.6%6.5%6.1 $7.53
1/15/20233,340,000 shares $22.98 million -17.5%5.9%5.4 $6.88
12/30/20224,050,000 shares $29.00 million +3.3%7.1%6.8 $7.16
12/15/20223,920,000 shares $26.93 million +0.8%6.9%5.3 $6.87
11/30/20223,890,000 shares $35.67 million -2.5%6.9%5.7 $9.17
11/15/20223,990,000 shares $32.12 million -1.0%7.0%6.1 $8.05
10/31/20224,030,000 shares $26.56 million -1.2%7.3%7 $6.59
10/15/20224,080,000 shares $24.60 million +7.9%7.4%6.7 $6.03
9/30/20223,780,000 shares $18.94 million -4.6%6.9%5.3 $5.01
9/15/20223,960,000 shares $23.64 million +2.1%7.2%5.4 $5.97
8/31/20223,880,000 shares $25.76 million -14.0%7.1%4.8 $6.64
8/15/20224,510,000 shares $30.98 million -4.0%8.2%1.2 $6.87
7/31/20224,700,000 shares $22.23 million -12.2%8.7%1.2 $4.73
7/15/20225,350,000 shares $25.25 million -5.5%13.5%1.3 $4.72
6/30/20225,660,000 shares $13.81 million -5.0%14.2%1.4 $2.44













AVDL Short Interest - Frequently Asked Questions

What is Avadel Pharmaceuticals' current short interest?

Short interest is the volume of Avadel Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of February 15th, investors have sold 8,860,000 shares of AVDL short. Learn More on Avadel Pharmaceuticals' current short interest.

What is a good short interest ratio for Avadel Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AVDL shares currently have a short interest ratio of 9.0. Learn More on Avadel Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Avadel Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Avadel Pharmaceuticals: Wolverine Trading LLC, Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Avadel Pharmaceuticals' short interest increasing or decreasing?

Avadel Pharmaceuticals saw a increase in short interest in the month of February. As of February 15th, there was short interest totaling 8,860,000 shares, an increase of 4.5% from the previous total of 8,480,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Avadel Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Avadel Pharmaceuticals: Tango Therapeutics, Inc. (19.10%), Collegium Pharmaceutical, Inc. (22.29%), ANI Pharmaceuticals, Inc. (1.04%), Arcturus Therapeutics Holdings Inc. (18.57%), Avidity Biosciences, Inc. (10.43%), Geron Co. (8.02%), Verve Therapeutics, Inc. (22.97%), Belite Bio, Inc (0.17%), Centessa Pharmaceuticals plc (2.85%), Amylyx Pharmaceuticals, Inc. (9.58%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Super Micro Computer, Inc. ($5.32 billion), T-Mobile US, Inc. ($4.38 billion), General Motors ($3.76 billion), Occidental Petroleum Co. ($3.08 billion), Charter Communications, Inc. ($2.65 billion), Coinbase Global, Inc. ($2.62 billion), Tractor Supply ($2.52 billion), Moderna, Inc. ($2.19 billion), Rivian Automotive, Inc. ($1.84 billion), and Royal Caribbean Cruises Ltd. ($1.78 billion). View all of the most shorted stocks.

What does it mean to sell short Avadel Pharmaceuticals stock?

Short selling AVDL is an investing strategy that aims to generate trading profit from Avadel Pharmaceuticals as its price is falling. AVDL shares are trading up $0.94 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Avadel Pharmaceuticals?

A short squeeze for Avadel Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AVDL, which in turn drives the price of the stock up even further.

How often is Avadel Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AVDL, twice per month. The most recent reporting period available is February, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:AVDL) was last updated on 3/1/2024 by MarketBeat.com Staff